Cargando…

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders

Nutritional ketosis, induced via either the classical ketogenic diet or the use of emulsified medium-chain triglycerides, is an established treatment for pharmaceutical resistant epilepsy in children and more recently in adults. In addition, the use of oral ketogenic compounds, fractionated coconut...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Gerwyn, Maes, Michael, Berk, Michael, Carvalho, André F., Puri, Basant K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057392/
https://www.ncbi.nlm.nih.gov/pubmed/32093791
http://dx.doi.org/10.1192/j.eurpsy.2019.13
_version_ 1783680825415434240
author Morris, Gerwyn
Maes, Michael
Berk, Michael
Carvalho, André F.
Puri, Basant K.
author_facet Morris, Gerwyn
Maes, Michael
Berk, Michael
Carvalho, André F.
Puri, Basant K.
author_sort Morris, Gerwyn
collection PubMed
description Nutritional ketosis, induced via either the classical ketogenic diet or the use of emulsified medium-chain triglycerides, is an established treatment for pharmaceutical resistant epilepsy in children and more recently in adults. In addition, the use of oral ketogenic compounds, fractionated coconut oil, very low carbohydrate intake, or ketone monoester supplementation has been reported to be potentially helpful in mild cognitive impairment, Parkinson’s disease, schizophrenia, bipolar disorder, and autistic spectrum disorder. In these and other neurodegenerative and neuroprogressive disorders, there are detrimental effects of oxidative stress, mitochondrial dysfunction, and neuroinflammation on neuronal function. However, they also adversely impact on neurone–glia interactions, disrupting the role of microglia and astrocytes in central nervous system (CNS) homeostasis. Astrocytes are the main site of CNS fatty acid oxidation; the resulting ketone bodies constitute an important source of oxidative fuel for neurones in an environment of glucose restriction. Importantly, the lactate shuttle between astrocytes and neurones is dependent on glycogenolysis and glycolysis, resulting from the fact that the astrocytic filopodia responsible for lactate release are too narrow to accommodate mitochondria. The entry into the CNS of ketone bodies and fatty acids, as a result of nutritional ketosis, has effects on the astrocytic glutamate–glutamine cycle, glutamate synthase activity, and on the function of vesicular glutamate transporters, EAAT, Na(+), K(+)-ATPase, K(ir)4.1, aquaporin-4, Cx34 and K(ATP) channels, as well as on astrogliosis. These mechanisms are detailed and it is suggested that they would tend to mitigate the changes seen in many neurodegenerative and neuroprogressive disorders. Hence, it is hypothesized that nutritional ketosis may have therapeutic applications in such disorders.
format Online
Article
Text
id pubmed-8057392
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-80573922021-05-04 Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders Morris, Gerwyn Maes, Michael Berk, Michael Carvalho, André F. Puri, Basant K. Eur Psychiatry Review/Meta-analyses Nutritional ketosis, induced via either the classical ketogenic diet or the use of emulsified medium-chain triglycerides, is an established treatment for pharmaceutical resistant epilepsy in children and more recently in adults. In addition, the use of oral ketogenic compounds, fractionated coconut oil, very low carbohydrate intake, or ketone monoester supplementation has been reported to be potentially helpful in mild cognitive impairment, Parkinson’s disease, schizophrenia, bipolar disorder, and autistic spectrum disorder. In these and other neurodegenerative and neuroprogressive disorders, there are detrimental effects of oxidative stress, mitochondrial dysfunction, and neuroinflammation on neuronal function. However, they also adversely impact on neurone–glia interactions, disrupting the role of microglia and astrocytes in central nervous system (CNS) homeostasis. Astrocytes are the main site of CNS fatty acid oxidation; the resulting ketone bodies constitute an important source of oxidative fuel for neurones in an environment of glucose restriction. Importantly, the lactate shuttle between astrocytes and neurones is dependent on glycogenolysis and glycolysis, resulting from the fact that the astrocytic filopodia responsible for lactate release are too narrow to accommodate mitochondria. The entry into the CNS of ketone bodies and fatty acids, as a result of nutritional ketosis, has effects on the astrocytic glutamate–glutamine cycle, glutamate synthase activity, and on the function of vesicular glutamate transporters, EAAT, Na(+), K(+)-ATPase, K(ir)4.1, aquaporin-4, Cx34 and K(ATP) channels, as well as on astrogliosis. These mechanisms are detailed and it is suggested that they would tend to mitigate the changes seen in many neurodegenerative and neuroprogressive disorders. Hence, it is hypothesized that nutritional ketosis may have therapeutic applications in such disorders. Cambridge University Press 2020-01-31 /pmc/articles/PMC8057392/ /pubmed/32093791 http://dx.doi.org/10.1192/j.eurpsy.2019.13 Text en © Cambridge University Press 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review/Meta-analyses
Morris, Gerwyn
Maes, Michael
Berk, Michael
Carvalho, André F.
Puri, Basant K.
Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title_full Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title_fullStr Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title_full_unstemmed Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title_short Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
title_sort nutritional ketosis as an intervention to relieve astrogliosis: possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders
topic Review/Meta-analyses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057392/
https://www.ncbi.nlm.nih.gov/pubmed/32093791
http://dx.doi.org/10.1192/j.eurpsy.2019.13
work_keys_str_mv AT morrisgerwyn nutritionalketosisasaninterventiontorelieveastrogliosispossibletherapeuticapplicationsinthetreatmentofneurodegenerativeandneuroprogressivedisorders
AT maesmichael nutritionalketosisasaninterventiontorelieveastrogliosispossibletherapeuticapplicationsinthetreatmentofneurodegenerativeandneuroprogressivedisorders
AT berkmichael nutritionalketosisasaninterventiontorelieveastrogliosispossibletherapeuticapplicationsinthetreatmentofneurodegenerativeandneuroprogressivedisorders
AT carvalhoandref nutritionalketosisasaninterventiontorelieveastrogliosispossibletherapeuticapplicationsinthetreatmentofneurodegenerativeandneuroprogressivedisorders
AT puribasantk nutritionalketosisasaninterventiontorelieveastrogliosispossibletherapeuticapplicationsinthetreatmentofneurodegenerativeandneuroprogressivedisorders